Desoxycorticosterone acetate API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Desoxycorticosterone acetate API 56-47-3?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Desoxycorticosterone acetate. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Desoxycorticosterone acetate
- Synonyms:
- 11-deoxycorticosterone acetate , Deoxycorticosterone acetate , Desoxycorticosterone-21-acetate , Desoxycortone acetate , DOCA
- Cas Number:
- 56-47-3
- DrugBank number:
- DB06780
- Unique Ingredient Identifier:
- 6E0A168OB8
General Description:
Desoxycorticosterone acetate is a chemical compound identified by the CAS number 56-47-3. It is known for its distinct pharmacological properties and applications.
Classification:
Desoxycorticosterone acetate belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety, classified under the direct parent group Gluco/mineralocorticoids, progestogins and derivatives. This compound is a part of the Organic compounds, falling under the Lipids and lipid-like molecules superclass, and categorized within the Steroids and steroid derivatives class, specifically within the Pregnane steroids subclass.
Categories:
Desoxycorticosterone acetate is categorized under the following therapeutic classes: Adrenal Cortex Hormones, Corticosteroids, Cytochrome P-450 CYP3A Substrates, Cytochrome P-450 CYP3A4 Substrates, Cytochrome P-450 Substrates, Desoxycorticosterone, Fused-Ring Compounds, Hormones, Hormones, Hormone Substitutes, and Hormone Antagonists, Hydroxycorticosteroids, Mineralocorticoids, Pregnanes, Pregnenediones, Pregnenes, Steroids. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Desoxycorticosterone acetate is a type of Electrolytes
Electrolytes are a crucial category of pharmaceutical active pharmaceutical ingredients (APIs) that play a vital role in maintaining the balance of essential ions in the body. These ions include sodium, potassium, calcium, magnesium, and chloride, among others. Electrolytes are responsible for maintaining proper hydration, regulating nerve and muscle function, and supporting various physiological processes.
In the pharmaceutical industry, electrolytes are widely utilized in the formulation of oral rehydration solutions, intravenous fluids, and dialysis solutions. These medications are employed to treat conditions such as dehydration, electrolyte imbalances, and renal dysfunction.
The availability of high-quality electrolyte APIs is of utmost importance to ensure the efficacy and safety of these pharmaceutical products. Pharmaceutical manufacturers rely on reputable suppliers who adhere to stringent quality control measures and comply with Good Manufacturing Practices (GMP) to produce electrolyte APIs of consistent quality.
To meet regulatory requirements, electrolyte APIs undergo rigorous testing to confirm their identity, purity, and potency. This includes analysis using advanced techniques such as high-performance liquid chromatography (HPLC), mass spectrometry (MS), and atomic absorption spectroscopy (AAS).
In conclusion, electrolytes are a vital category of pharmaceutical APIs used to maintain the balance of essential ions in the body. They are extensively employed in various medications aimed at treating dehydration, electrolyte imbalances, and renal dysfunction. Pharmaceutical manufacturers prioritize the use of high-quality electrolyte APIs to ensure the safety and efficacy of their products, and adherence to stringent regulatory standards is crucial in their production and testing processes.
